For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Mitotix, Inc.

USPTO Granted Patents = 16

Forward Citations = 237

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Giulio Draetta (11 out of 12 patents)

Mark Rolfe (6 out of 8 patents)

Guillaume Cottarel (6 out of 10 patents)

4. Veronique Damagnez (5 out of 14 patents)

5. Jeno Gyuris (4 out of 10 patents)

6. Vivian Berlin (3 out of 13 patents)

7. Lou Lamphere (3 out of 4 patents)

8. Peggy L Beer-Romero (2 out of 3 patents)

9. Maria Isabel Chiu (2 out of 6 patents)

10. Jens W Eckstein (2 out of 2 patents)

11. Kollol Pal (1 out of 9 patents)

12. Serene Josiah (1 out of 6 patents)

13. Yoshikazu Ohya (1 out of 3 patents)

14. David H Beach (1 out of 34 patents)

15. David E Levin (1 out of 2 patents)

16 patents: Sort by Forward Citations

1. 6251585 - Assay and reagents for identifying anti-proliferative agents (2001-06-26),

2. 6146842 - High-throughput screening assays utilizing metal-chelate capture (2000-11-14),

3. 6117641 - Assays and reagents for identifying anti-fungal agents and uses related (2000-09-12),

4. 6068982 - Ubiquitin conjugating enzymes (2000-05-30),

5. 6060262 - Regulation of I Kappa B (I.kappa.B) degradation and methods and reagents (2000-05-09),

6. 6015692 - CDC37 cell-cycle regulatory protein and uses related thereto (2000-01-18),

7. 5981699 - Human ubiquitin conjugating enzyme (1999-11-09),

8. 5968761 - Ubiquitin conjugating enzymes (1999-10-19),

9. 5858987 - E6AP antisense constructs and methods of use (1999-01-12),

10. 5801015 - Nucleic acid encoding a Candida cell cycle regulatory protein, TYP1 (1998-09-01),

11. 5756671 - CDC37 cell-cycle regulatory protein, and uses related thereto (1998-05-26),

12. 5744343 - Ubiquitin conjugating enzymes (1998-04-28),

13. 5733920 - Inhibitors of cyclin dependent kinases (1998-03-31),

14. 5691147 - CDK4 binding assay (1997-11-25),

15. 5672508 - Inhibitors of cell-cycle progression, and uses related thereto (1997-09-30),

Mitotix, Inc. is a leading biotechnology company specializing in cell-based assays and drug discovery services. Our innovative technologies and expertise in cell biology support pharmaceutical and biotech companies in accelerating their drug development process. With a focus on precision medicine, Mitotix offers customized solutions to meet the specific needs of our clients. Visit our website to learn more about how we can help you advance your drug discovery research.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 20 2026

16 Patents

#139 in Cambridge, MA

#1,165 in Massachusetts

#19,350 in US

#36,755 in the World

Cambridge, MA, United States of America

Mitotix, Inc.

Forward Citations = 237

20 inventors:

Giulio Draetta (11 out of 12 patents)

Mark Rolfe (6 out of 8 patents)

Guillaume Cottarel (6 out of 10 patents)

4. Veronique Damagnez (5 out of 14 patents)

5. Jeno Gyuris (4 out of 10 patents)

Please report any incorrect information to support@idiyas.com

Loading…